首頁 > 市場調查報告書 > 製藥

癌症呼吸器

2030 年亞太地區肺癌治療市場預測 - 區域分析 - 按治療類型、適應症和最終用戶

市場調查報告書

商品編碼

1494401

2030 年亞太地區肺癌治療市場預測 - 區域分析 - 按治療類型、適應症和最終用戶

Asia Pacific Lung Cancer Therapy Market Forecast to 2030 - Regional Analysis - By Therapy Type, Indication, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 118 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太地區肺癌治療市值為37.7803億美元，預計2030年將達到109.6326億美元；預計2022年至2030年複合年成長率為14.2%。

肺癌病例的增加推動亞太地區肺癌治療市場

肺癌是全世界死亡的主要原因之一。如果及早診斷，這種類型的癌症可以得到更有效的治療。因此，肺癌高風險族群需要接受常規檢查，以檢測肺部癌變的形成。在全球範圍內，肺癌是男性最常見的癌症，也是女性第二常見的癌症。根據世界衛生組織 (WHO) 的數據，肺癌是全球男性和女性癌症相關死亡的主要原因。根據世界癌症研究基金會國際報告，2020 年全球新增肺癌病例約 220 萬例。男性 7,707 人，女性 6,822 人。 2022 年，近 9% 的新登記癌症病例被診斷出來，估計有 8,664 人死於肺癌。此外，根據印度醫學委員會（ICMR）的研究，到2025年，印度的肺癌病例數預計將比十年前同期增加七倍以上。因此，全球肺癌發生率的上升促進了肺癌治療的研發活動，進而推動了市場的成長。

亞太地區肺癌治療市場概況

過去幾年，由於吸菸、菸草消費等多種因素，中國肺癌盛行率不斷上升。根據國際癌症研究機構報告，2020 年中國新增肺癌病例約 82 萬例，肺癌相關死亡病例約 71.5 萬例。此外，影像導引經皮肺消融術已被證明是治療肺癌和其他肺部惡性腫瘤的有效替代方法。

亞太地區肺癌治療市場收入及 2030 年預測（百萬美元）

亞太地區肺癌治療市場細分

亞太地區肺癌治療市場根據治療類型、適應症、最終用戶和國家進行細分。

根據治療類型，亞太地區肺癌治療市場分為非侵入性治療和微創治療。到2022年，非侵入性細分市場將佔更大佔有率。

有跡象表明，亞太地區肺癌治療市場分為非小細胞肺癌和小細胞肺癌。 2022 年，非小細胞肺癌細分市場將佔據更大佔有率。

依最終用戶分類，亞太地區肺癌治療市場分為醫院、腫瘤診所、研究中心等。 2022 年，醫院領域佔最大佔有率。

依國家/地區分類，亞太地區肺癌治療市場分為中國、日本、印度、澳洲、韓國、東南亞和亞太地區其他地區。 2022年，中國在亞太地區肺癌治療市場佔據主導地位。

Medtronic Plc、RF Medical Co Ltd、Johnson & Johnson、Merck KGaA、Sun Pharmaceutical Industries Ltd、Bioventus Inc、Olympus Corp、Meiji Seika Pharma Co Ltd 和 Advanz Pharma Corp 是亞太地區肺癌治療領域的一些領先公司市場。

Lung cancer is among the main causes of mortality across the world. This type of cancer can be treated more effectively if it is diagnosed early. Therefore, people at a high risk of lung cancer need to undergo routine testing to detect the formation of cancerous growth inside their lungs. Globally lung cancer is the most common cancer in men and the second most common cancer in women. According to the World Health Organization (WHO), lung cancer is the leading cause of cancer-related deaths globally, in both men and women. As per the World Cancer Research Fund International, ~2.2 million new lung cancer cases were registered worldwide in 2020. As per the Cancer Australia 2023 report, ~14,529 new lung cancer cases were diagnosed in 2022; 7,707 were males and 6,822 were females. Nearly 9% of registered new cancer cases were diagnosed in 2022, with an estimated 8,664 deaths from lung cancer. Also, according to studies from the Indian Council of Medical (ICMR), the number of lung cancer cases in India is expected to increase by more than seven times by 2025 when compared to the same period a decade earlier. Thus, the rising incidence of lung cancer worldwide is contributing to the research and development activities for lung cancer therapy, which is, in turn, driving the market growth.

Asia Pacific Lung Cancer Therapy Market Overview

China has experienced the increasing prevalence of lung cancer over the past few years owing to the various factors including smoking, tobacco consumption, and others. As per the International Agency for Research on Cancer reported that approximately 820,000 new lung cancer diagnoses and 715,000 lung cancer-related deaths occurred in China in 2020. A few of the primary causes of lung cancer in China include tobacco use, radiation exposure, family history, and the presence of chronic lung diseases. Further, image-guided percutaneous lung ablation has proven to be an effective alternative approach for the treatment of lung cancer and other lung malignancies.

Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Lung Cancer Therapy Market Segmentation

The Asia Pacific lung cancer therapy market is segmented based on therapy type, indication, end user, and country.

Based on therapy type, the Asia Pacific lung cancer therapy market is bifurcated into noninvasive and minimally invasive. The noninvasive segment held a larger share in 2022. The minimally invasive segment is further subsegmented into radiofrequency ablation, microwave ablation, thermal ablation, cryoablation, chemical ablation, photodynamic ablation, and others.

By indication, the Asia Pacific lung cancer therapy market is bifurcated into non-small cell lung cancer and small cell lung cancer. The non-small cell lung cancer segment held a larger share in 2022.

By end user, the Asia Pacific lung cancer therapy market is segmented into hospitals, oncology clinics, research centers, and others. The hospitals segment held the largest share in 2022.

Based on country, the Asia Pacific lung cancer therapy market is segmented into China, Japan, India, Australia, South Korea, Southeast Asia, and the Rest of Asia Pacific. China dominated the Asia Pacific lung cancer therapy market in 2022.

Medtronic Plc, RF Medical Co Ltd, Johnson & Johnson, Merck KGaA, Sun Pharmaceutical Industries Ltd, Bioventus Inc, Olympus Corp, Meiji Seika Pharma Co Ltd, and Advanz Pharma Corp are some of the leading companies operating in the Asia Pacific lung cancer therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Asia Pacific Lung Cancer Therapy Market, by Country

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Lung Cancer Therapy Market - Key Industry Dynamics

4.1 Market Drivers:
- 4.1.1 Increase in Cases of Lung Cancer
- 4.1.2 Government Initiatives for Screening and Treatment of Lung Cancer
4.2 Market Restraints
- 4.2.1 High Cost of Lung Cancer Therapy
4.3 Market Opportunities
- 4.3.1 Rising Number of Lung Cancer Therapy in Clinical Trials
4.4 Future Trends
- 4.4.1 Growing Demand for Targeted Therapy
4.5 Impact Analysis:

5. Lung Cancer Therapy Market - Asia Pacific Market Analysis

5.1 Asia Pacific Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Therapy Type

6.1 Overview
6.2 Asia Pacific Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)
6.3 Non-Invasive Therapy
- 6.3.1 Overview
- 6.3.2 Non-Invasive Therapy: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Minimally Invasive
- 6.4.1 Overview
- 6.4.2 Minimally Invasive: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4.3 Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

7. Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Indication

7.1 Overview
7.2 Asia Pacific Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
7.3 Non-Small Cell Lung Cancer
- 7.3.1 Overview
- 7.3.2 Non-Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Small Cell Lung Cancer
- 7.4.1 Overview
- 7.4.2 Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Asia Pacific Lung Cancer Therapy Market Revenue Share, by End User, 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Oncology Clinics
- 8.4.1 Overview
- 8.4.2 Oncology Clinics: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Research Centers
- 8.5.1 Overview
- 8.5.2 Research Centers: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Lung Cancer Therapy Market - Country Analysis

9.1.1 Asia Pacific Asia Pacific Lung Cancer Therapy Market, by Country
- 9.1.1.1 China
  - 9.1.1.1.1 Overview
  - 9.1.1.1.2 China: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.1.3 China: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.1.3.1 China: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.1.4 China: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.1.5 China: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
- 9.1.1.2 Japan
  - 9.1.1.2.1 Overview
  - 9.1.1.2.2 Japan: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.2.3 Japan: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.2.3.1 Japan: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.2.4 Japan: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.2.5 Japan: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
- 9.1.1.3 India
  - 9.1.1.3.1 Overview
  - 9.1.1.3.2 India Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.3.3 India: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.3.3.1 India: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.3.4 India: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.3.5 India: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
- 9.1.1.4 Australia
  - 9.1.1.4.1 Overview
  - 9.1.1.4.2 Australia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.4.3 Australia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.4.3.1 Australia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.4.4 Australia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.4.5 Australia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
- 9.1.1.5 South Korea
  - 9.1.1.5.1 Overview
  - 9.1.1.5.2 South Korea: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.5.3 South Korea: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.5.3.1 South Korea: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.5.4 South Korea: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.5.5 South Korea: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
- 9.1.1.6 Southeast Asia
  - 9.1.1.6.1 Overview
  - 9.1.1.6.2 Southeast Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.3 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.3.1 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.4 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.5 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
  - 9.1.1.6.6 Singapore
  - 9.1.1.6.6.1 Singapore: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.6.2 Singapore: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.6.2.1 Singapore: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.6.3 Singapore: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.6.4 Singapore: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
  - 9.1.1.6.7 Malaysia
  - 9.1.1.6.7.1 Malaysia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.7.2 Malaysia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.7.2.1 Malaysia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.7.3 Malaysia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.7.4 Malaysia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
  - 9.1.1.6.8 Indonesia
  - 9.1.1.6.8.1 Indonesia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.8.2 Indonesia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.8.2.1 Indonesia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.8.3 Indonesia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.8.4 Indonesia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
  - 9.1.1.6.9 Vietnam
  - 9.1.1.6.9.1 Vietnam: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.9.2 Vietnam: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.9.2.1 Vietnam: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.9.3 Vietnam: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.9.4 Vietnam: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
  - 9.1.1.6.10 Cambodia
  - 9.1.1.6.10.1 Cambodia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.10.2 Cambodia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.10.2.1 Cambodia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.10.3 Cambodia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.10.4 Cambodia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
  - 9.1.1.6.11 Philippines
  - 9.1.1.6.11.1 Philippines: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.11.2 Philippines: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.11.2.1 Philippines: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.11.3 Philippines: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.11.4 Philippines: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
  - 9.1.1.6.12 Rest of Southeast Asia
  - 9.1.1.6.12.1 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.6.12.2 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.6.12.2.1 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.6.12.3 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.6.12.4 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
- 9.1.1.7 Rest of Asia Pacific
  - 9.1.1.7.1 Overview
  - 9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
  - 9.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
  - 9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
  - 9.1.1.7.5 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

10. Lung Cancer Therapy Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Asia Pacific Lung Cancer Therapy Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 RF Medical Co Ltd
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Johnson & Johnson
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Merck KGaA
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Sun Pharmaceutical Industries Ltd
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Bioventus Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Olympus Corp
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Meiji Seika Pharma Co Ltd
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Advanz Pharma Corp
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Lung Cancer Therapy Market Segmentation
Table 2. Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. South Korea: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 24. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 25. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 26. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 27. Singapore: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 28. Singapore: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 29. Singapore: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 30. Singapore: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 31. Malaysia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 32. Malaysia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 33. Malaysia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 34. Malaysia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 35. Indonesia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 36. Indonesia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 37. Indonesia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 38. Indonesia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 39. Vietnam: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 40. Vietnam: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 41. Vietnam: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 42. Vietnam: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 43. Cambodia Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 44. Cambodia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 45. Cambodia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 46. Cambodia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 47. Philippines: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 48. Philippines: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 49. Philippines: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 50. Philippines: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 51. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 52. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 56. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 57. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 58. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 59. Recent Inorganic Growth Strategies in the Asia Pacific Lung Cancer Therapy Market
Table 60. Recent Organic Growth Strategies in Asia Pacific Lung Cancer Therapy Market
Table 61. Glossary of Terms, Asia Pacific Lung Cancer Therapy Market

List Of Figures

Figure 1. Asia Pacific Lung Cancer Therapy Market Segmentation, By Country
Figure 2. Asia Pacific Lung Cancer Therapy Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)
Figure 6. Non-Invasive Therapy: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Minimally Invasive: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
Figure 9. Non-Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Lung Cancer Therapy Market Revenue Share, End User, 2022 & 2030 (%)
Figure 12. Hospitals: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oncology Clinics: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Research Centers: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific Asia Pacific Lung Cancer Therapy Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 17. Asia Pacific Asia Pacific Lung Cancer Therapy Market, By Key Countries, 2022 and 2030 (%)
Figure 18. China: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. Japan: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 20. India: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Australia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. South Korea: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Southeast: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Singapore: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Malaysia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Indonesia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Vietnam: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Cambodia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Philippines: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Growth Strategies in Asia Pacific Lung Cancer Therapy Market